{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:13:50Z","timestamp":1793812430161,"version":"4.6.1"},"reference-count":131,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Osteoporosis-related fractures are undertreated, due in part to misinformation about recommended approaches to patient care and discrepancies among treatment guidelines. To help bridge this gap and improve patient outcomes, the American Society for Bone and Mineral Research assembled a multistakeholder coalition to develop clinical recommendations for the optimal prevention of secondary fractureamong people aged 65 years and older with a hip or vertebral fracture. The coalition developed 13 recommendations (7 primary and 6 secondary) strongly supported by the empirical literature. The coalition recommends increased communication with patients regarding fracture risk, mortality and morbidity outcomes, and fracture risk reduction. Risk assessment (including fall history) should occur at regular intervals with referral to physical and\/or occupational therapy as appropriate. Oral, intravenous, andsubcutaneous pharmacotherapies are efficaciousandcanreduce risk of future fracture.Patientsneededucation,however, about thebenefitsandrisks of both treatment and not receiving treatment. Oral bisphosphonates alendronate and risedronate are first-line options and are generally well tolerated; otherwise, intravenous zoledronic acid and subcutaneous denosumab can be considered. Anabolic agents are expensive butmay be beneficial for selected patients at high risk.Optimal duration of pharmacotherapy is unknown but because the risk for second fractures is highest in the earlypost-fractureperiod,prompt treatment is recommended.Adequate dietary or supplemental vitaminDand calciumintake shouldbe assured. Individuals beingtreatedfor osteoporosis shouldbe reevaluated for fracture risk routinely, includingvia patienteducationabout osteoporosisandfracturesandmonitoringfor adverse treatment effects.Patients shouldbestronglyencouraged to avoid tobacco, consume alcohol inmoderation atmost, and engage in regular exercise and fall prevention strategies. Finally, referral to endocrinologists or other osteoporosis specialists may be warranted for individuals who experience repeated fracture or bone loss and those with complicating comorbidities (eg, hyperparathyroidism, chronic kidney disease).\u00a92019American Society for Bone andMineral Research.<\/jats:p>","DOI":"10.1097\/bot.0000000000001743","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T10:33:02Z","timestamp":1584700382000},"page":"e125-e141","source":"Crossref","is-referenced-by-count":13,"title":["Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition"],"prefix":"10.1097","volume":"34","author":[{"given":"Robert B","family":"Conley","sequence":"first","affiliation":[{"name":"Center for Medical Technology Policy, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Adib","sequence":"additional","affiliation":[{"name":"Osteoporosis Centre, Damascus, Syria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Adler","sequence":"additional","affiliation":[{"name":"McGuire VA Medical Center, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina E","family":"\u00c5kesson","sequence":"additional","affiliation":[{"name":"Lund University and Sk\u00e5ne University Hospital, Lund, Scania, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy M","family":"Alexander","sequence":"additional","affiliation":[{"name":"UConn School of Nursing, University of Connecticut, Storrs, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C","family":"Amenta","sequence":"additional","affiliation":[{"name":"Department of Physician Assistant Studies, Mercyhurst University, Erie, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Blank","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Clinical Nutrition, Medical College of Wisconsin, Milwaukee, WI, USA"},{"name":"Garvan Institute of Medical Research, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Timothy","family":"Brox","sequence":"additional","affiliation":[{"name":"UCSF Fresno, Fresno, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E","family":"Carmody","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Chapman-Novakofski","sequence":"additional","affiliation":[{"name":"Division of Nutritional Sciences, University of Illinois, Urbana, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L","family":"Clarke","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Cody","sequence":"additional","affiliation":[{"name":"American Bone Health, Raleigh, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J","family":"Crandall","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R","family":"Dirschl","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Rehabilitation Medicine, University of Chicago Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Eagen","sequence":"additional","affiliation":[{"name":"National Council on Aging, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L","family":"Elderkin","sequence":"additional","affiliation":[{"name":"American Society for Bone and Mineral Research, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Science Department, International Osteoporosis Foundation, Nyon, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Greenspan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Halbout","sequence":"additional","affiliation":[{"name":"International Osteoporosis Foundation, Nyon, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C","family":"Hochberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Maryland School of Medicine and VA Maryland Health Care System, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Javaid","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J","family":"Jeray","sequence":"additional","affiliation":[{"name":"Prisma Health - Upstate (formerly Greenville Health System), Greenville, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E","family":"Kearns","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"King","sequence":"additional","affiliation":[{"name":"US Bone and Joint Initiative, Rosemont, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Koinis","sequence":"additional","affiliation":[{"name":"Duke Primary Care Oxford, Oxford, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Scott","family":"Koontz","sequence":"additional","affiliation":[{"name":"Orthopedics & Sports Medicine, Newton Medical Center, Newton, KS, USA"},{"name":"Department of Family and Community Medicine, University of Kansas School of Medicine, Wichita, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ku\u017ema","sequence":"additional","affiliation":[{"name":"5th Department of Internal Medicine, University Hospital, Comenius University, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleen","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Bones, Backs and Balance, LLC, Bristol Physical Therapy, LLC, Bristol, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Lorentzon","sequence":"additional","affiliation":[{"name":"Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia"},{"name":"Department of Geriatric Medicine, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"Geriatric Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P","family":"Lyritis","sequence":"additional","affiliation":[{"name":"Hellenic Osteoporosis Foundation, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Boehnke","family":"Michaud","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Miciano","sequence":"additional","affiliation":[{"name":"Nevada Rehabilitation Institute, Las Vegas, NV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne N","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Mujahid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Metabolic Disorders, Campus Bio-Medico University of Rome, Rome, Italy"},{"name":"Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P","family":"Olenginski","sequence":"additional","affiliation":[{"name":"HiROC Program\/Rheumatology, Geisinger Health System, Danville, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Edward","family":"Puzas","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Rizou","sequence":"additional","affiliation":[{"name":"Hellenic Osteoporosis Foundation, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J","family":"Rosen","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, MA, USA"},{"name":"Maine Medical Center Research Institute, Portland, ME, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Saag","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thompson","sequence":"additional","affiliation":[{"name":"National Osteoporosis Foundation, Arlington, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L","family":"Tosi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Sports Medicine, Children\u2019s National Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Tracer","sequence":"additional","affiliation":[{"name":"Center for Evidence and Practice Improvement, Agency for Healthcare Research and Quality, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P","family":"Kiel","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Musculoskeletal Research Center, Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"8","key":"R1-20230828","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla S","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"R2-20230828","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"4","key":"R3-20230828","first-page":"461","article-title":"Prevalence and cost of subsequent fractures among U.S. patients with an incident fracture","volume":"23","author":"Weaver","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"10","key":"R4-20230828","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention","volume":"27","author":"Eisman JA","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"R5-20230828","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/annrheumdis-2016-210289","article-title":"EULAR\/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures","volume":"76","author":"Lems","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","article-title":"Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis","volume":"111","author":"Wu CH","year":"2018","journal-title":"Bone"},{"issue":"5","key":"R7-20230828","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-017-4370-z","article-title":"Identifying characteristics of an effective fracture liaison service: systematic literature review","volume":"29","author":"Wu","year":"2018","journal-title":"Osteoporos Int"},{"issue":"2","key":"R9-20230828","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00198-017-4270-2","article-title":"Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis","volume":"29","author":"Dunn","year":"2018","journal-title":"Osteoporos Int"},{"issue":"2","key":"R10-20230828","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00198-014-2967-z","article-title":"High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized","volume":"26","author":"Olenginski TP","year":"2015","journal-title":"Osteoporos Int"},{"issue":"4","key":"R11-20230828","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00198-017-4371-y","article-title":"Implementing a fracture liaison service open model of care utilizing a cloud-based tool","volume":"29","author":"Greenspan","year":"2018","journal-title":"Osteoporos Int"},{"issue":"Suppl 2","key":"R12-20230828","first-page":"30","article-title":"Establishing and implementing a fracture liaison service","volume":"76","author":"Stephenson","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"R19-20230828","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/M15-1361","article-title":"Clinical guidelines Committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"R20-20230828","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4158\/EP161435.ESGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2013 2016\u2014executive summary","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"R21-20230828","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UKclinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston J","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"11","key":"R22-20230828","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","article-title":"Pre-existing fractures and bone mass predict vertebral fracture incidence in women","volume":"114","author":"Ross PD","year":"1991","journal-title":"Ann Intern Med"},{"issue":"2","key":"R23-20230828","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis JA","year":"2004","journal-title":"Bone"},{"issue":"23","key":"R24-20230828","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1001\/jama.298.23.2761","article-title":"Long-term risk of incident vertebral fractures","volume":"298","author":"Cauley JA","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"R25-20230828","first-page":"346","article-title":"Death","volume":"69","author":"Tajeu GS","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"R26-20230828","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.injury.2016.04.018","article-title":"Quality of life after hip fracture in the elderly: a systematic literature review","volume":"47","author":"Peeters CM","year":"2016","journal-title":"Injury"},{"issue":"6","key":"R27-20230828","first-page":"1343","article-title":"Prediction of survival","volume":"50","author":"Kim SM","year":"2012","journal-title":"Bone"},{"issue":"11","key":"R28-20230828","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.injury.2015.07.024","article-title":"Complications and patient-reported outcome after hip fracture. A consecutive annual cohort study of 664 patients","volume":"46","author":"Hansson S","year":"2015","journal-title":"Injury"},{"issue":"3","key":"R29-20230828","first-page":"252","article-title":"Surgical treatment of hip fractures: factors influencing mortality","volume":"17","author":"Dailiana Z","year":"2013","journal-title":"Hippokratia"},{"issue":"2","key":"R30-20230828","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOT.0000000000000448","article-title":"Factors predicting mobility and the change in activities of daily living after hip fracture: a 1-year prospective cohort study","volume":"30","author":"Mariconda M","year":"2016","journal-title":"J Orthop Trauma"},{"issue":"37","key":"R31-20230828","doi-asserted-by":"crossref","first-page":"e7820","DOI":"10.1097\/MD.0000000000007820","article-title":"Predictors of noninstitutionalized survival 1 year after hip fracture: a prospective observational study to develop the Marburg rehabilitation tool for hip fractures (MaRTHi)","volume":"96","author":"Buecking B","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"R32-20230828","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/jgs.14921","article-title":"A survey of women\u2019s awareness of and reasons for lack of postfracture osteoporotic care","volume":"65","author":"Boudreau","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"R33-20230828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11657-018-0470-4","article-title":"Expressed information needs of patients with osteoporosis and\/or fragility fractures: a systematic review","volume":"13","author":"Raybould G","year":"2018","journal-title":"Arch Osteoporos"},{"issue":"8","key":"R35-20230828","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.165.8.905","article-title":"Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients","volume":"165","author":"Majumdar","year":"2005","journal-title":"Arch Intern Med"},{"issue":"10","key":"R36-20230828","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4329\/wjr.v2.i10.399","article-title":"Incidental vertebral compression fractures in imaging studies: lessons not learned by radiologists","volume":"2","author":"Bartalena","year":"2010","journal-title":"World J Radiol"},{"issue":"1","key":"R37-20230828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12891-018-2171-y","article-title":"The prevalence and under-diagnosis of vertebral fractures on chest radiograph","volume":"19","author":"Li","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"R38-20230828","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11657-017-0363-y","article-title":"Reporting of vertebral fragility fractures: can radiologists help reduce the number of hip fractures?","volume":"12","author":"Mitchell RM","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"1","key":"R39-20230828","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel TA","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"R40-20230828","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/gerona\/glt092","article-title":"Epidemiology of fracture risk with advancing age","volume":"68","author":"Ensrud KE","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R41-20230828","first-page":"CD007146","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"R42-20230828","first-page":"190","article-title":"Do all hip fractures result from a fall?","volume":"28","author":"Youm T","year":"1999","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"R43-20230828","first-page":"9","article-title":"Epidemiology of falls and osteoporotic fractures: a systematic review","volume":"5","author":"Morrison A","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"16","key":"R48-20230828","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2018.3097","article-title":"Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"R49-20230828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis JA","year":"2019","journal-title":"Osteoporos Int"},{"issue":"4","key":"R50-20230828","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jamda.2017.12.013","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs","volume":"19","author":"de Vries","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"R51-20230828","first-page":"371","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: II","volume":"19","author":"Seppala","year":"2018","journal-title":"Psychotropics. J Am Med Dir Assoc."},{"issue":"4","key":"R52-20230828","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40266-018-0622-7","article-title":"EuGMS task and finish group on fall-risk-increasing drugs (FRIDs): position on knowledge dissemination, management, and future research","volume":"36","author":"Seppala","year":"2019","journal-title":"Drugs Aging"},{"issue":"7","key":"R53-20230828","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jdiacomp.2015.05.016","article-title":"Risk factors associated with falls in elderly patients with type 2 diabetes","volume":"29","author":"Chiba","year":"2015","journal-title":"J Diabetes Complications"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2318-13-125","article-title":"Characteristics of outdoor falls among older people: a qualitative study","volume":"13","author":"Nyman","year":"2013","journal-title":"BMC Geriatr"},{"issue":"4","key":"R55-20230828","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/psyg.12217","article-title":"Falls, risk factors and fear of falling among persons older than 65 years of age","volume":"17","author":"Gazibara","year":"2017","journal-title":"Psychogeriatrics"},{"issue":"1","key":"R57-20230828","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","article-title":"Panel on Prevention of Falls in Older Persons, AGS\/BGS. Summary of the updated American Geriatrics Society\/British Geriatrics Society clinical practice guideline for prevention of falls in older persons","volume":"59","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"R58-20230828","article-title":"Implementation of the Stopping Elderly Accidents, Deaths, and Injuries Initiative in primary care: an outcome evaluation","author":"Johnston","year":"2018 Sep 20","journal-title":"Gerontologist"},{"issue":"5","key":"R61-20230828","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00198-017-3911-9","article-title":"The importance of physical function to people with osteoporosis","volume":"28","author":"Kerr","year":"2017","journal-title":"Osteoporos Int"},{"issue":"5","key":"R62-20230828","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S8756-3282(99)00202-1","article-title":"Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group","volume":"25","author":"Nevitt","year":"1999","journal-title":"Bone"},{"issue":"Suppl 2","key":"R63-20230828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13697137.2015.1092342","article-title":"FRAX and fracture prediction without bone mineral density","volume":"18","author":"Kanis","year":"2015","journal-title":"Climacteric"},{"issue":"10","key":"R64-20230828","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"6","key":"R65-20230828","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R66-20230828","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the International Task Force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"R67-20230828","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"R68-20230828","first-page":"1391","article-title":"Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J Rheumatol"},{"issue":"17","key":"R69-20230828","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1080\/14656566.2016.1241765","article-title":"Healing of the bone with anti-fracture drugs","volume":"17","author":"Vannucci","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"R70-20230828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1749-799X-9-45","article-title":"Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials","volume":"9","author":"Xue","year":"2014","journal-title":"J Orthop Surg Res"},{"issue":"8","key":"R71-20230828","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.injury.2018.04.016","article-title":"The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs","volume":"49","author":"Hak","year":"2018","journal-title":"Injury"},{"issue":"8","key":"R72-20230828","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","article-title":"Association between timing of zoledronic acid infusion and hip fracture healing","volume":"22","author":"Colon-Emeric","year":"2011","journal-title":"Osteoporos Int"},{"issue":"1","key":"R73-20230828","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12894-018-0393-9","article-title":"Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion","volume":"18","author":"Body","year":"2018","journal-title":"BMC Urol"},{"issue":"1","key":"R75-20230828","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12888-016-1130-0","article-title":"Electrolyte disorders and aging: risk factors for delirium in patients undergoing orthopedic surgeries","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"3","key":"R78-20230828","first-page":"1309","article-title":"Hypocalcaemia after total knee arthroplasty and its clinical significance","volume":"36","author":"Gai","year":"2016","journal-title":"Anticancer Res"},{"issue":"3","key":"R79-20230828","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00198-016-3819-9","article-title":"Surgery alters parameters of vitamin D status and other laboratory results","volume":"28","author":"Binkley","year":"2017","journal-title":"Osteoporos Int"},{"issue":"8","key":"R80-20230828","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1210\/jcem.84.8.5889","article-title":"Hypocalcemia induced during major and minor abdominal surgery in humans","volume":"84","author":"Lepage","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"R81-20230828","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"R82-20230828","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risk factors for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R83-20230828","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/DDDT.S6287","article-title":"Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass","volume":"4","author":"Hamdy","year":"2010","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"R84-20230828","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4158\/EP161638.OR","article-title":"Acute phase reactions after zoledronic acid infusion: protective role of 25-hydroxyvitamin D and previous oral bisphosphonate therapy","volume":"24","author":"Crotti","year":"2018","journal-title":"Endocr Pract"},{"issue":"12","key":"R89-20230828","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/M16-1743","article-title":"Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology","volume":"165","author":"Kopecky","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"R90-20230828","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","article-title":"Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States","volume":"90","author":"Singer","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"R91-20230828","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s00198-005-1949-6","article-title":"Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"16","author":"Sawka","year":"2005","journal-title":"Osteoporos Int"},{"issue":"6","key":"R92-20230828","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jep.12800","article-title":"Osteoporotic fractures may impair life as much as the complications of diabetes","volume":"23","author":"Voko","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"R93-20230828","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00198-014-2963-3","article-title":"Mediating effects on healthrelated quality of life in adults with osteoporosis: a structural equation modeling","volume":"26","author":"Huang","year":"2015","journal-title":"Osteoporos Int"},{"issue":"3","key":"R94-20230828","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"R95-20230828","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clinthera.2017.11.008","article-title":"The good and the bad about the 2017 American College of Physicians Osteoporosis Guidelines","volume":"40","author":"Lagari","year":"2018","journal-title":"Clin Ther"},{"issue":"3","key":"R97-20230828","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-15-0118","article-title":"Management of endocrine disease: secondary osteoporosis: pathophysiology and management","volume":"173","author":"Mirza","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R98-20230828","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bone.2018.08.019","article-title":"Longtermtimetrends inuse of medications associated with risk of developing osteoporosis: nationwide data for Denmark from 1999 to 2016","volume":"120","author":"Ostadahmadli","year":"2019","journal-title":"Bone"},{"issue":"1","key":"R100-20230828","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00198-015-3356-y","article-title":"Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study","volume":"27","author":"Fink","year":"2016","journal-title":"Osteoporos Int"},{"issue":"6","key":"R101-20230828","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00198-010-1421-0","article-title":"Osteoporosis in men: the value of laboratory testing","volume":"22","author":"Ryan","year":"2011","journal-title":"Osteoporos Int"},{"issue":"10","key":"R102-20230828","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R104-20230828","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11657-016-0260-9","article-title":"Quality assessment of osteoporosis clinical practice guidelines for physical activity and safe movement: an AGREE II appraisal","volume":"11","author":"Armstrong","year":"2016","journal-title":"Arch Osteoporos"},{"key":"R105-20230828","first-page":"CD000333","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","volume":"7","author":"Howe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R106-20230828","first-page":"CD008618","article-title":"Exercise for improving outcomes after osteoporotic vertebral fracture","volume":"1","author":"Giangregorio","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"R107-20230828","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11597670-000000000-00000","article-title":"Effects of training on bone mass in older adults: a systematic review","volume":"42","author":"Gomez-Cabello","year":"2012","journal-title":"Sports Med"},{"issue":"2","key":"R108-20230828","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1519\/00139143-200708000-00007","article-title":"Effect of weighted exercises on bone mineral density in post menopausal women. A systematic review","volume":"30","author":"Zehnacker","year":"2007","journal-title":"J Geriatr Phys Ther"},{"issue":"11","key":"R109-20230828","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00198-013-2346-1","article-title":"The effect of physical exercise on bone density in middle-aged and older men: a systematic review","volume":"24","author":"Bolam","year":"2013","journal-title":"Osteoporos Int"},{"issue":"2","key":"R110-20230828","first-page":"92","article-title":"Osteoporosis: a review of treatment options","volume":"43","author":"Tu","year":"2018","journal-title":"P T"},{"issue":"5","key":"R111-20230828","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jamda.2018.02.005","article-title":"Can bisphosphonates prevent recurrent fragility fractures? A systematic review and metaanalysis of randomized controlled trials","volume":"19","author":"Lee","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"R112-20230828","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R113-20230828","first-page":"CD004523","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"R114-20230828","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.injury.2017.12.016","article-title":"Atypical fractures: an issue of concern or a myth?","volume":"49","author":"Al-Ashqar","year":"2018","journal-title":"Injury"},{"issue":"1","key":"R115-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"2","key":"R116-20230828","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"R117-20230828","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11914-018-0464-6","article-title":"Current understanding of epidemiology, pathophysiology, and management of atypical femur fractures","volume":"16","author":"Starr","year":"2018","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"R118-20230828","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-014-0606-6","article-title":"Atypical femoral fracture in a patient treated with denosumab","volume":"33","author":"Khow","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"R119-20230828","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00198-015-3354-0","article-title":"Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report","volume":"27","author":"Ramchand","year":"2016","journal-title":"Osteoporos Int"},{"issue":"2","key":"R120-20230828","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00198-015-3355-z","article-title":"Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review","volume":"27","author":"Selga","year":"2016","journal-title":"Osteoporos Int"},{"issue":"12","key":"R121-20230828","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"issue":"12","key":"R122-20230828","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"R123-20230828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"R124-20230828","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1302\/2046-3758.63.BJR-2016-0125.R1","article-title":"Bisphosphonates and atypical subtrochanteric fractures of the femur","volume":"6","author":"Kharwadkar","year":"2017","journal-title":"Bone Joint Res"},{"key":"R125-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.02.006","article-title":"Symptomatic atypical femoral fractures are related to underlying hip geometry","volume":"63","author":"Taormina","year":"2014","journal-title":"Bone"},{"issue":"1","key":"R126-20230828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","article-title":"Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review","volume":"21","author":"Khow","year":"2017","journal-title":"J Nutr Health Aging"},{"issue":"11","key":"R128-20230828","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","article-title":"Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center","volume":"28","author":"Koh","year":"2017","journal-title":"Osteoporos Int"},{"issue":"1","key":"R129-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbm4.10024","article-title":"Genetic risk factors for atypical femoral fractures (AFFs): a systematic review","volume":"2","author":"Nguyen","year":"2018","journal-title":"JBMR Plus"},{"issue":"8","key":"R130-20230828","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jbmr.3164","article-title":"Screening for atypical femur fractures using extended femur scans by DXA","volume":"32","author":"van de Laarschot","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"2","key":"R131-20230828","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiol.13122691","article-title":"Detection of prefracture hip lesions in atypical subtrochanteric fracture with dual-energy x-ray absorptiometry images","volume":"270","author":"Kim","year":"2014","journal-title":"Radiology"},{"issue":"9","key":"R132-20230828","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"R134-20230828","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"issue":"3","key":"R135-20230828","first-page":"18","article-title":"The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance","volume":"66","author":"Abed","year":"2018","journal-title":"Gen Dent"},{"issue":"4","key":"R136-20230828","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10266-018-0362-5","article-title":"Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis","volume":"106","author":"Voss","year":"2018","journal-title":"Odontology"},{"issue":"2","key":"R137-20230828","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00520-013-2017-y","article-title":"Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies","volume":"22","author":"Lee","year":"2014","journal-title":"Support Care Cancer"},{"issue":"10","key":"R138-20230828","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medicationrelated osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"R139-20230828","doi-asserted-by":"crossref","first-page":"e0196419","DOI":"10.1371\/journal.pone.0196419","article-title":"The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects","volume":"13","author":"ChiuWY","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"R140-20230828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jebdp.2017.11.002","article-title":"Recommendations for the prevention of bisphosphonate-related osteonecrosis of the jaw: a systematic review","volume":"18","author":"Aparecida Cariolatto","year":"2018","journal-title":"J Evid Based Dent Pract"},{"issue":"2","key":"R141-20230828","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.4317\/medoral.20963","article-title":"Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review","volume":"21","author":"Diniz-Freitas","year":"2016","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"10","key":"R142-20230828","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00198-018-4621-7","article-title":"Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study","volume":"29","author":"Shudo","year":"2018","journal-title":"Osteoporos Int"},{"issue":"6","key":"R143-20230828","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-018-4506-9","article-title":"A proposal for an atypical femur fracture treatment and prevention clinical practice guideline","volume":"29","author":"Dell","year":"2018","journal-title":"Osteoporos Int"},{"issue":"18","key":"R144-20230828","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"R145-20230828","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00198-016-3736-y","article-title":"Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in efficacy to osteoporosis; ZONE study)","volume":"28","author":"Nakamura","year":"2017","journal-title":"Osteoporos Int"},{"issue":"6","key":"R146-20230828","doi-asserted-by":"crossref","first-page":"1000336","DOI":"10.4172\/2167-0870.1000336","article-title":"Design of a multicenter, randomized, open label, parallel group study to evaluate the efficacy of loxoprofen on acute-phase reactions in Japanese primary osteoporosis patients treated with zoledronic acid","volume":"7","author":"Okimoto","year":"2017","journal-title":"J Clin Trials"},{"issue":"12","key":"R147-20230828","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"8","key":"R148-20230828","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"R149-20230828","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2169\/internalmedicine.8618-16","article-title":"Management of osteoporosis in chronic kidney disease","volume":"56","author":"Nitta","year":"2017","journal-title":"Intern Med"},{"issue":"9","key":"R150-20230828","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"R151-20230828","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"8","key":"R152-20230828","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/js.2018-00118","article-title":"Osteoanabolic agents for osteoporosis","volume":"2","author":"Haas","year":"2018","journal-title":"J Endocr Soc"},{"issue":"7","key":"R153-20230828","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00198-018-4504-y","article-title":"Review of the guideline of the American College of Physicians on the treatment of osteoporosis","volume":"29","author":"Kanis","year":"2018","journal-title":"Osteoporos Int"},{"key":"R155-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.09.020","article-title":"Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: a systematic review and meta-analysis","volume":"120","author":"Diez-Perez","year":"2019","journal-title":"Bone"},{"issue":"11","key":"R156-20230828","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/GME.0000000000000757","article-title":"Long-term bisphosphonates: primum non nocere","volume":"23","author":"Ott","year":"2016","journal-title":"Menopause"},{"issue":"1","key":"R157-20230828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/M19-0533","article-title":"Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review","volume":"171","author":"Fink","year":"2019","journal-title":"Ann Intern Med"},{"issue":"12","key":"R159-20230828","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s00198-017-4215-9","article-title":"Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk","volume":"28","author":"Mignot","year":"2017","journal-title":"Osteoporos Int"},{"issue":"7","key":"R161-20230828","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jbmr.3420","article-title":"Bisphosphonate drug holiday and fracture risk: a population-based cohort study","volume":"33","author":"Adams","year":"2018","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T07:31:45Z","timestamp":1693207905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":131,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000001743","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}